113
Views
14
CrossRef citations to date
0
Altmetric
Original Investigations

The prevalence and predictive value of individual criteria for metabolic syndrome in schizophrenia: A Northern Finland 1966 Birth Cohort Study

, , , , , , , & show all
Pages 262-267 | Received 11 Aug 2008, Accepted 17 Sep 2008, Published online: 10 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Joachim Cordes, Johanna Thünker, Gunnar Regenbrecht, Jürgen Zielasek, Christoph U. Correll, Christian Schmidt-Kraepelin, Christian Lange-Asschenfeldt, Marcus W. Agelink, Kai G. Kahl, Wolfgang Gaebel, Ansgar Klimke & Hans Hauner. (2014) Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial. The World Journal of Biological Psychiatry 15:3, pages 229-241.
Read now

Articles from other publishers (13)

Richard Drake. 2020. Seminars in Clinical Psychopharmacology. Seminars in Clinical Psychopharmacology 326 349 .
Chen Lin, Ke Chen, Rongzhen Zhang, Weihong Fu, Jianjin Yu, Lan Gao, Haiqing Ni, Jiaqi Song & Dachun Chen. (2020) The prevalence, risk factors, and clinical characteristics of insulin resistance in Chinese patients with schizophrenia. Comprehensive Psychiatry 96, pages 152145.
Crossref
L. N. Gorobets, M. A. Tsarenko, A. V. Litvinov & L. M. Vasilenko. (2019) Frequency of occurrence of type 2 diabetes and metabolic disturbances in patients with schizophrenic range disorders with prolonged anti-relapse antipsychotic therapy (based on screening results). V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY:2, pages 37-45.
Crossref
E. G. Kornetova, V. V. Dubrovskaya, A. N. Kornetov, O. A. Lobacheva, S. A. Ivanova & A. V. Semke. (2018) Morphophenotypic predictor of the development of visceral obesity in patients with schizophrenia receiving antipsychotic therapy. Bulletin of Siberian Medicine 17:4, pages 54-64.
Crossref
Gabriel Fernando Oviedo, Carlos Gómez Restrepo, Adriana Bohórquez Peñaranda, Jenny García Valencia, Luis Eduardo Jaramillo, Nathalie Tamayo, María Luisa Arenas & Carolina Vélez Fernández. (2015) Evaluación y seguimiento metabólico del paciente con diagnóstico de esquizofrenia. Revista Colombiana de Psiquiatría 44:4, pages 220-229.
Crossref
Erika Jääskeläinen, Marianne Haapea, Nina Rautio, Pauliina Juola, Matti Penttilä, Tanja Nordström, Ina Rissanen, Anja Husa, Emmi Keskinen, Riikka Marttila, Svetlana Filatova, Tiina-Mari Paaso, Jenni Koivukangas, Kristiina Moilanen, Matti Isohanni & Jouko Miettunen. (2015) Twenty Years of Schizophrenia Research in the Northern Finland Birth Cohort 1966: A Systematic Review. Schizophrenia Research and Treatment 2015, pages 1-12.
Crossref
Man K. Chan, Michael G. Gottschalk, Frieder Haenisch, Jakub Tomasik, Tillmann Ruland, Hassan Rahmoune, Paul C. Guest & Sabine Bahn. (2014) Applications of blood-based protein biomarker strategies in the study of psychiatric disorders. Progress in Neurobiology 122, pages 45-72.
Crossref
Cyrus S. H. Ho, Melvyn W. B. Zhang, Anselm Mak & Roger C. M. Ho. (2018) Metabolic syndrome in psychiatry: advances in understanding and management. Advances in Psychiatric Treatment 20:2, pages 101-112.
Crossref
Evangelos Papanastasiou. (2012) The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review. Therapeutic Advances in Psychopharmacology 3:1, pages 33-51.
Crossref
Ina Rissanen, Erika Jääskeläinen, Matti Isohanni, Hannu Koponen, Matti Joukamaa, Antti Alaräisänen & Jouko Miettunen. (2012) Use of antipsychotic medication and suicidality-the Northern Finland Birth Cohort 1966. Human Psychopharmacology: Clinical and Experimental 27:5, pages 476-485.
Crossref
Hwa-Young LeeJung-Eun Choi. (2012) Prevalence of the Metabolic Syndrome among Outpatients with Schizophrenia or Schizoaffective Disorder. Korean Journal of Schizophrenia Research 15:1, pages 39.
Crossref
Naira R. Matevosyan. (2011) Schizophrenia and Stein–Leventhal syndrome: comorbidity features. Archives of Gynecology and Obstetrics 284:4, pages 1035-1041.
Crossref
Nam Young Lee, Se Hyun Kim, Dong Chung Jung, Eun Young Kim, Han Young Yu, Ki Hye Sung, Ung Gu Kang, Yong Min Ahn & Yong Sik Kim. (2011) The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:5, pages 1273-1278.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.